Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
Jae Young Oh, Byung Seok Kim, Chang Hyeong Lee, Jeong Eun Song, Heon Ju Lee, Jung Gil Park, Jae Seok Hwang, Woo Jin Chung, Byoung Kuk Jang, Young Oh Kweon, Won Young Tak, Soo Young Park, Se Young Jang, Jeong Ill Suh, Sang Gyu Kwak
Korean J Intern Med. 2019;34(4):794-801. Published online 2018 May 25 DOI: https://doi.org/10.3904/kjim.2017.368
Citations to this article as recorded by 
Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus
Ahmed N. Farrag, Ahmed M. Kamel, Iman A. ElâBaraky
Reviews in Medical Virology.2024;[Epub] CrossRef
Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation
Nirmeen Sabry, Ahmed M. Kamel, Ahmed Cordie, Gamal Esmat
Expert Opinion on Pharmacotherapy.2023; 24(2): 159. CrossRef
Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
Medicina.2023; 59(8): 1436. CrossRef
Current therapeutics against HCV
Chayan Bhattacharjee, Maitri Singh, Debisukti Das, Sujit Chaudhuri, Aparna Mukhopadhyay
VirusDisease.2021; 32(2): 228. CrossRef
Asunaprevir/daclatasvir
Reactions Weekly.2019; 1770(1): 61. CrossRef